NEUROCRINE BIOSCIENCES, INC.

CA

Drug discovery and development

Filings
19
Firms Hired
1
Total Expenses
—
Years Active
2020–2024

Filings

All 20242023202220212020
YearFirmPeriodExpensesDoc
2024 RICCHETTI INCORPORATED 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination 		—
2024 RICCHETTI INCORPORATED 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2024 RICCHETTI INCORPORATED 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2024 RICCHETTI INCORPORATED 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2024 RICCHETTI INCORPORATED 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2023 RICCHETTI INCORPORATED 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
2023 RICCHETTI INCORPORATED 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		—
2023 RICCHETTI INCORPORATED 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		—
2023 RICCHETTI INCORPORATED 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		—
2022 RICCHETTI INCORPORATED 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		—
Page 1 of 2  ·  19 filings Next
Firms Hired
FirmFilingsExpenses
RICCHETTI INCORPORATED 19 —
Issue Areas
IssueActivities
Medicare/Medicaid 19
Health Issues 17
Pharmacy 17
Insurance 2
Financial Institutions/Investments/Securities 2
Budget/Appropriations 1
Taxation/Internal Revenue Code 1
Medical/Disease Research/Clinical Labs 1

Bills Mentioned in Filings

S. 2678